Eli Lilly's Bid for Accelerated Approval of Its Alzheimer's Therapy Donanemab Was ... - Latest Tweet by Bloomberg
The latest Tweet by Bloomberg states, 'Eli Lilly’s bid for accelerated approval of its Alzheimer’s therapy donanemab was rejected by US regulators, an unexpected setback for the drugmaker ...'
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)